Authors:
Park, P
Haas, M
Cunningham, PN
Alexander, JJ
Bao, L
Guthridge, JM
Kraus, DM
Holers, VM
Quigg, RJ
Citation: P. Park et al., Inhibiting the complement system does not reduce injury in renal ischemia reperfusion, J AM S NEPH, 12(7), 2001, pp. 1383-1390
Authors:
Guthridge, JM
Young, K
Gipson, MG
Sarrias, MR
Szakonyi, G
Chen, XJS
Malaspina, A
Donoghue, E
James, JA
Lambris, JD
Moir, SA
Perkins, SJ
Holers, VM
Citation: Jm. Guthridge et al., Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: Identification of a highly inhibitory monoclonalantibody that directly recognizes the CR2-C3d interface, J IMMUNOL, 167(10), 2001, pp. 5758-5766
Authors:
Rehrig, S
Fleming, SD
Anderson, J
Guthridge, JM
Rakstang, J
McQueen, CE
Holers, VM
Tsokos, GC
Shea-Donohue, T
Citation: S. Rehrig et al., Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal mesenteric ischemia/reperfusion damage after the onset ofinjury in mice, J IMMUNOL, 167(10), 2001, pp. 5921-5927
Authors:
Guthridge, JM
Rakstang, JK
Young, KA
Hinshelwood, J
Aslam, M
Robertson, A
Gipson, MG
Sarrias, MR
Moore, WT
Meagher, M
Karp, D
Lambris, JD
Perkins, SJ
Holers, VM
Citation: Jm. Guthridge et al., Structural studies in solution of the recombinant N-terminal pair of shortconsensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg, BIOCHEM, 40(20), 2001, pp. 5931-5941
Authors:
Cunningham, PN
Holers, VM
Alexander, JJ
Guthridge, JM
Carroll, MC
Quigg, RJ
Citation: Pn. Cunningham et al., Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure, KIDNEY INT, 58(4), 2000, pp. 1580-1587
Authors:
Nichols, TC
Guthridge, JM
Karp, DR
Molina, H
Fletcher, DR
Holers, VM
Citation: Tc. Nichols et al., gamma-glutamyl transpeptidase, an ecto-enzyme regulator of intracellular redox potential, is a component of TM4 signal transduction complexes, EUR J IMMUN, 28(12), 1998, pp. 4123-4129